- Issuer ticker
-
SRXH
- Reported as of
-
24 Jun 2024
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
03 Apr 2026, 11:04:57 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Carolina Martinez, Attorney-in- fact
Key filing fact
Kent Douglas Cunningham filed Form 4 for SRx Health Solutions, Inc. (SRXH) on 03 Apr 2026.
Key facts
- This page summarizes Kent Douglas Cunningham's Form 4 filing for SRx Health Solutions, Inc. (SRXH).
- 9 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Apr 2026, 11:04.
Change
- Previous filing in this sequence was filed on 03 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002097408
Primary reporting owner
Cunningham Kent Douglas
- Relationship
-
Chief Executive Officer
- Address
- 801 US HIGHWAY 1, NORTH PALM BEACH
- Signature
- /s/ Carolina Martinez, Attorney-in- fact
- Signature date
- 03 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRXH
transaction
Common Stock
Award
- Transaction value
- Shares
- +200,000
- Change %
- +44%
- Price
-
$0.3900*
- Shares after
- 655,060
- Date
- 03 Dec 2025
- Ownership
- Direct
SRXH
transaction
Common Stock
Award
- Transaction value
- Shares
- +44,464
- Change %
- +11%
- Price
-
$0.3300*
- Shares after
- 455,060
- Date
- 26 Sep 2025
- Ownership
- Indirectly owned through ownership in Halo Spin-Out SPV Inc.
SRXH
transaction
Common Stock
Award
- Transaction value
- Shares
- +231,193
- Change %
- +129%
- Price
-
$0.4040*
- Shares after
- 410,596
- Date
- 25 Aug 2025
- Ownership
- Direct
SRXH
transaction
Common Stock
Award
- Transaction value
- Shares
- +84,906
- Change %
- +90%
- Price
-
$1.59*
- Shares after
- 179,403
- Date
- 25 Apr 2025
- Ownership
- Direct
SRXH
transaction
Common Stock
Award
- Transaction value
- Shares
- +71,770
- Change %
- +316%
- Price
-
$2.09*
- Shares after
- 94,497
- Date
- 24 Apr 2025
- Ownership
- Direct
SRXH
transaction
Common Stock
Award
- Transaction value
- Shares
- +22,727
- Change %
- Price
-
$4.17*
- Shares after
- 22,727
- Date
- 26 Jun 2024
- Ownership
- Direct
SRXH
transaction
Series B Preferred Stock
Award
- Transaction value
- Shares
- +63
- Change %
- Price
-
$800.00*
- Shares after
- 63
- Date
- 16 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SRXH
transaction
Derivative
Stock Options - Right to Buy
Award
- Transaction value
- Shares
- +8,000
- Change %
- Price
-
$5.00*
- Shares after
- 8,000
- Date
- 26 Jun 2024
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 8,000
- Exercise price
- $5.00
SRXH
transaction
Derivative
Series B Warrants
Award
- Transaction value
- Shares
- +247,522
- Change %
- Price
-
$0.3182*
- Shares after
- 247,522
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 247,522
- Exercise price
- $0.3182
* marks a reported price that did not pass the local price check.